Drug Profile
Research programme: antibody-drug conjugates - APO-T
Alternative Names: AIM-1; AIM-2; AIMs; Apoptosis Inducing Molecules - APO-TLatest Information Update: 07 Nov 2021
Price :
$50
*
At a glance
- Originator APO-T
- Class Antibodies; Drug conjugates
- Mechanism of Action Apoptosis stimulants; MAGEA 3 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in Netherlands
- 22 Mar 2013 Research in Cancer in Netherlands (unspecified route)